Related Experiment Video

Updated: May 17, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Opportunities in proteomics to understand hepatitis C and HIV coinfection

Eric G Meissner1, Anthony F Suffredini, Shyamasundaran Kottilil

  • 1Laboratory of Immunoregulation, National Institute of Allergy & Infectious Diseases, Bethesda, MD 20892, USA.

Future Virology
|October 30, 2012
PubMed

Insights

HIV and Hepatitis C virus coinfection complicates liver disease progression and treatment outcomes. Proteomics offers new insights into understanding these interactions and identifying clinical predictors for better patient management.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Antiretroviral therapy (ART) has improved HIV outcomes, but Hepatitis C virus (HCV) coinfection complicates disease progression.
  • HIV significantly accelerates liver fibrosis and cirrhosis in coinfected individuals compared to HCV monoinfection.
  • Understanding the interplay between HIV, HCV, the immune system, and liver fibrogenesis is crucial.

Purpose of the Study:

  • To review advances in proteomics for studying HIV and HCV.
  • To highlight coinfection challenges addressable by proteomic discovery.
  • To focus on clinical predictors of liver fibrosis and treatment outcomes in coinfected patients.

Main Methods:

  • Review of recent advances in proteomics applied to HIV and HCV research.
  • Analysis of clinical data and literature concerning HIV-HCV coinfection.
  • Identification of key areas for future proteomic investigation.

Main Results:

  • HIV accelerates liver disease progression and impairs treatment response in HCV coinfection.
  • Proteomic approaches can elucidate viral interactions and host responses.
  • Clinical predictors of fibrosis and treatment outcomes are key targets for discovery.

Conclusions:

  • Proteomics provides valuable tools for understanding complex HIV-HCV coinfection.
  • Further proteomic research can identify biomarkers for fibrosis and treatment success.
  • Focusing on clinical applicability will translate research findings into improved patient care.

More Related Videos

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells10:24

SILAC Based Proteomic Characterization of Exosomes from HIV-1 Infected Cells

Published on: March 3, 2017

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...